NASDAQ: ENTO
Entero Therapeutics Inc Stock Ownership - Who owns Entero Therapeutics?

Insider buying vs selling

Have Entero Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sarah RomanoChief Financial Officer2025-01-06727$0.64
$465.28Sell
Sarah RomanoChief Financial Officer2024-10-09476$0.45
$212.30Sell

1 of 1

ENTO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ENTO insiders and whales buy or sell their stock.

ENTO Shareholders

What type of owners hold Entero Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Edmund Burke Ross Jr.191.40%3,040,555$12.34MInsider
Pelican Partners LLC102.47%1,627,796$6.61MInsider
Johan M. Spoor26.33%418,319$1.70MInsider
Charles J. Casamento8.62%136,935$555.96kInsider
David Andrew Hoffman5.71%90,778$368.56kInsider
Vern Lee Schramm5.70%90,498$367.42kInsider
Maged Shenouda3.93%62,500$253.75kInsider
Geode Capital Management LLC2.30%36,560$148.43kInstitution
James Sapirstein2.25%35,816$145.41kInsider
Edward Borkowski2.14%33,928$137.75kInsider

1 of 3

ENTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENTO2.06%97.94%Net Selling
ADIL1.08%21.16%
IBO3.87%17.31%Net Selling
CANF0.02%0.00%
VYNE23.70%76.30%Net SellingNet Selling

Entero Therapeutics Stock Ownership FAQ

Who owns Entero Therapeutics?

Entero Therapeutics (NASDAQ: ENTO) is owned by 7.49% institutional shareholders, 355.77% Entero Therapeutics insiders, and 0.00% retail investors. Edmund Burke Ross Jr. is the largest individual Entero Therapeutics shareholder, owning 3.04M shares representing 191.40% of the company. Edmund Burke Ross Jr.'s Entero Therapeutics shares are currently valued at $14.53M.

If you're new to stock investing, here's how to buy Entero Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.